Novo Nordisk looks to build existing business in Japan in launchless 2012
This article was originally published in Scrip
Executive Summary
Novo Nordisk is developing what it views as its strongest ever pipeline in Japan, but faces a lull in new product launches this year before the series of new products begins to reach the market.